CorMedix Inc.CRMDNASDAQ
Loading
Gross Profit Growth Under PressureDecelerating
Percentile Rank54
3Y CAGR-67.6%
Year-over-Year Change
Year-over-year gross profit growth rate
3Y CAGR
-67.6%/yr
Quarterly compound
Percentile
P54
Within normal range
vs 3Y Ago
0x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 15.28% |
| Q3 2025 | 145.76% |
| Q2 2025 | 1.04% |
| Q1 2025 | 24.81% |
| Q4 2024 | 178.88% |
| Q3 2024 | 3534.91% |
| Q2 2024 | 136.20% |
| Q1 2024 | -1429.78% |
| Q4 2023 | -3.17% |
| Q3 2023 | -2.20% |
| Q2 2023 | -2.64% |
| Q1 2023 | -268.78% |
| Q4 2022 | 447.79% |
| Q3 2022 | -74.44% |
| Q2 2022 | 242.46% |
| Q1 2022 | -27.19% |
| Q4 2021 | -35.07% |
| Q3 2021 | 307.25% |
| Q2 2021 | -123.16% |
| Q1 2021 | 1871.18% |
| Q4 2020 | -111.60% |
| Q3 2020 | 578.18% |
| Q2 2020 | -110.73% |
| Q1 2020 | 219.63% |
| Q4 2019 | -9.49% |
| Q3 2019 | -237.90% |
| Q2 2019 | 122.35% |
| Q1 2019 | -1534.54% |
| Q4 2018 | -92.66% |
| Q3 2018 | 330.09% |
| Q2 2018 | -386.71% |
| Q1 2018 | -118.36% |
| Q4 2017 | 623.85% |
| Q3 2017 | -104.72% |
| Q2 2017 | 318.68% |
| Q1 2017 | -248.45% |
| Q4 2016 | 6777.88% |
| Q3 2016 | 100.31% |
| Q2 2016 | -1839.12% |
| Q1 2016 | 93.77% |